Atlas Trials

Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults

Clinical trial NCT04989972 · WITHDRAWN

Trial details

NCT number
NCT04989972
Sponsor
Wake Network, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Anxiety and Depression
Start date
2022-09-15
Primary completion
2023-06-20
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.